October 16-19, 2024 | New York City |
Pinkal Desai MD, MPH is an Associate Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital. She is the Clinical Director of Molecular Aging Institute at the Einglander Institue of Prescision Medicine, WCM. Dr. Desai serves in the Leukemia Program and has a clinical practice devoted to leukemia, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). She is actively involved in clinical and translational research protocols and projects in the areas of leukemia, MDS and MPN. Her expertise is in the clinical care of patients with these diseases and she serves as principal investigator and co-investigator of numerous investigator initiated and industry-sponsored clinical trials.
Dr. Desai’s research interests are in hematological malignancies particularly in the fields of myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and clonal hematopoiesis (CH). In addition she has a background in epidemiology and has a strong research interest in the epidemiology of hematological malignancies, particularly in studying preventative strategies in hematological malignancies with numerous publications in the field of cancer epidemiology.
Dr. Desai is published in Nature Medicine, British Journal of Haematology, Blood Advances, Cancer, Cancer Medicine, Cancer Epidemiology Biomarkers Prevention and International Journal of Molecular Epidemiology and Genetics. She is a member of American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) and has served on the ASCO University Committee.